Böger, R H <br/><br/>
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].  [electronic resource] 

 -  Deutsche medizinische Wochenschrift (1946)  Apr 2004 
 - 820-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0012-0472 
<br/><br/><label>Standard No.: </label>10.1055/s-2004-822880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Arginine--analogs & derivatives<br/>Arteriosclerosis--blood<br/>Biomarkers<br/>Cardiovascular Diseases--blood<br/>Case-Control Studies<br/>Cells, Cultured<br/>Child<br/>Coronary Disease--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Disease Models, Animal<br/>Endothelial Cells--drug effects<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Free Radicals<br/>Humans<br/>Hypertension--blood<br/>Kidney Failure, Chronic--blood<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Multivariate Analysis<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Oxidative Stress<br/>Pre-Eclampsia--blood<br/>Pregnancy<br/>Prospective Studies<br/>Rabbits<br/>Regression Analysis<br/>Renal Dialysis<br/>Risk Factors<br/>Stroke--blood